Search
Now showing items 1-2 of 2
Úloha mikroRNA v progresi kardiovaskulárních chorob
The Role of MicroRNAs in the Progression of Cardiovascular Diseases
dissertation thesis (DEFENDED)
Advisor: Pešta, Martin
Date Issued: 2022
Date of defense: 29. 06. 2022
Faculty / Institute: Lékařská fakulta v Plzni / Faculty of Medicine in Pilsen
Abstract: 1 Abstrakt Současný aplikovaný výzkum molekul mikroRNA je zaměřen na identifikaci jejich rolí v patogenezi různých typů onemocnění, včetně kardiovaskulárních (KV), a to s předpokladem jejich uplatnění jako biomarkerů nebo ...
Current applied research of microRNA molecules is focused on the identification of their roles in the pathogenesis of various types of diseases, including cardiovascular (CV), with the assumption of their use as biomarkers ...
Current applied research of microRNA molecules is focused on the identification of their roles in the pathogenesis of various types of diseases, including cardiovascular (CV), with the assumption of their use as biomarkers ...
Úloha buněčného metabolismu v karcinogenezi. Molekulární patofyziologie chemorezistence karcinomu močového měchýře
The Role of Cellular Metabolism in Carcinogenesis. Molecular Pathophysiology of Bladder Cancer Chemoresistance
dissertation thesis (DEFENDED)
Advisor: Kuncová, Jitka
Date Issued: 2019
Date of defense: 16. 09. 2019
Faculty / Institute: Lékařská fakulta v Plzni / Faculty of Medicine in Pilsen
Abstract: Terapeutická rezistence nádor p edstavuje závažný klinický problém. Z hlediska klinického pr b hu vzniku rezistentního fenotypu rozlišujeme primární rezistenci, kdy nádor v bec nereaguje na aplikovanou terapii, a rezistenci ...
Therapeutic resistance of tumours represents an important clinical issue. We can classify the therapeutic tumour resistance in two ways. According to the clinical course, tumours can behave either as primary resistant, ...
Therapeutic resistance of tumours represents an important clinical issue. We can classify the therapeutic tumour resistance in two ways. According to the clinical course, tumours can behave either as primary resistant, ...